Hims & Hers donates $1 million to Trump’s inauguration fund

Hims & Hers donates  million to Trump’s inauguration fund


Hims & Hers Health has donated $1 million to President-elect Donald Trump’s inauguration fund, CNBC confirmed Tuesday.

The company, which offers a range of direct-to-consumer treatments for conditions like weight loss, erectile dysfunction and hair loss, is the latest in a string of tech companies that have tried to curry favor with the incoming administration. OpenAI CEO Sam Altman and Meta both announced $1 million donations to the inaugural fund late last year, and Amazon and Apple CEO Tim Cook have also reportedly contributed.

“At Hims & Hers, we stand with leaders and advocates who are committed to improving America’s broken healthcare system,” the company said in a statement to CNBC.

Axios first reported Hims & Hers’ donation.

Hims & Hers was a breakout star in the digital health sector last year, largely thanks to the success of its popular new weight loss offering.

The company began prescribing compounded semaglutide through its platform in May after launching a weight loss program late in 2023. Semaglutide is the active ingredient in Novo Nordisk’s blockbuster medications Ozempic and Wegovy, which can cost around $1,000 a month without insurance. Compounded semaglutide is a cheaper, custom-made alternative to the brand drugs and can be produced when the brand-name treatments are in shortage.

The future of compounded GLP-1s in the U.S. is not entirely clear, especially as members of Trump’s circle have expressed conflicting opinions about the drugs more broadly. Robert F. Kennedy Jr.,  Trump’s pick to lead the Department of Health and Human Services, has criticized GLP-1s. He told CNBC in an interview that “the first line of response” to obesity should be lifestyle changes, though he added that “GLP drugs have a place.”

Dr. Marty Makary, Trump’s pick to lead the Food and Drug Administration, has served as an executive of the telehealth company Sesame, which connects consumers to physicians who can prescribe compounded GLP-1s. However, Makary’s role at Sesame has been mostly ceremonial in recent years. 

Elon Musk, the Tesla CEO who has been a close confidant of Trump’s since the election, has openly expressed his support for the medications.

“Nothing would do more to improve the health, lifespan and quality of life for Americans than making GLP inhibitors super low cost to the public,” Musk wrote in a post on his social media platform X in December.

At an event with reporters in New York City late last year, which was attended by CNBC, Hims & Hers said it would work with the incoming administration and share the company’s point of view about the value of the medications.



Source

Supreme Court endorses Obamacare panel that requires free preventive care
Health

Supreme Court endorses Obamacare panel that requires free preventive care

Demonstrators in support of U.S. President Barack Obama’s health-care law, the Affordable Care Act (ACA), hold up ‘ACA is Here to Stay’ signs after the U.S. Supreme Court ruled 6-3 to save Obamacare tax subsidies outside the Supreme Court in Washington, D.C. June 25, 2015. Andrew Harrer | Bloomberg | Getty Images WASHINGTON — The […]

Read More
Supreme Court rules for South Carolina over bid to defund Planned Parenthood
Health

Supreme Court rules for South Carolina over bid to defund Planned Parenthood

Planned Parenthood signage is displayed outside of a health care clinic in Los Angeles, California on May 16, 2023.  Patrick T. Fallon | AFP | Getty Images WASHINGTON — The Supreme Court on Thursday ruled for South Carolina over its effort to defund Planned Parenthood, concluding that individual Medicaid patients cannot sue to enforce their […]

Read More
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Health

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Competition in […]

Read More